After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

Most cases of COPD are linked to smoking, but other factors include inhaling pollutants like ammonia, asbestos and dust (archived here and here). The disease has no cure, but patients can improve ...

Share on Pinterest PongMoji/Getty Images Spirometry is an important tool for diagnosing and determining treatment for chronic obstructive pulmonary disease (COPD). This breathing test can detect ...

The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Following almost a decade of research, the Monash-led team hopes the discovery can eventually lead to an effective treatment for COPD. Researchers say COPD is mainly caused by smoking, but ...

Australian researchers have discovered that multiple chemicals found in cigarette smoke and e-cigarettes alter the function ...